Moneycontrol
HomeNewsBusinessEconomyCOVID-19 impact | India's economy to contract by 4% in FY21, says ADB
Trending Topics

COVID-19 impact | India's economy to contract by 4% in FY21, says ADB

"As food supply disruption is expected to ease from Q2 of FY21, inflation projections are unchanged at 3.0 percent for FY21 but revised up marginally to 4.0% for FY22 on accelerating demand," the report said.

June 18, 2020 / 15:23 IST
Story continues below Advertisement

The Indian economy is expected to contract by 4 percent in FY21, and then grow by 5 percent in FY22 as economic activity normalises gradually, the Asian Development Bank said on June 18.

"Growth in Indian GDP slowed to 3.1 percent  in the last quarter of FY20, its slowest since early 2003," the report said.

Story continues below Advertisement

Economic growth slowed to 4.2 percent in the whole of FY20 as both exports and investment started to contract. High-frequency indicators such as purchasing managers’ indexes fell to all-time lows in April, reflecting the bleak outlook, the report said.

"Migrant workers have gone home to their villages after losing their jobs in the cities and will be slow to return even after containment measures are relaxed," the report said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show